Shanghai Jiaolian Drug Research And Development Co., Ltd

This study tests a new drug, B007, in 132 people with pemphigus, a serious blistering skin disease. The goal is to see if B007 can help patients achieve complete remission while needing only minimal ongoing treatment. The trial is for newly diagnosed or relapsed patients and will…

This study tests an injection called B001 in 132 people with neuromyelitis optica spectrum disorder (NMOSD), a rare disease that causes attacks of inflammation in the eyes and spinal cord. The goal is to see if the drug can delay or prevent these attacks. Participants must have h…

This study tests whether adding the experimental drug B013 to standard chemotherapy (paclitaxel) can help people with ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based treatments. About 90 participants will receive either the comb…

This early-phase study tests a new injectable antibody (anti-CD20) for primary membranous nephropathy, a kidney disease where the immune system attacks the kidneys. The trial will enroll 52 adults to check safety, how the drug moves through the body, and whether it shows signs of…